Doctor Himanshu Rai
Mater Private Network, Dublin 7 (Ireland)
Membership:
FESC Member
EAPCI Member
Biography
My doctoral program revolved around understanding the underlying genetic mechanisms involved in the pathogenesis of coronary artery disease which I completed from Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS) and University of Lucknow, in Lucknow, India. I received my post-doctoral training in intravascular imaging with a world class research group of Prof. (Dr.) Adnan Kastrati at Intracoronary Stenting and Antithrombotic (ISA) Research Centre, Deutsches Herzzentrum München, in Munich Germany.
I am currently the Head of Imaging Core Laboratory at Cardiovascular Research Institute (CVRI) Dublin, Mater Private Hospital, Dublin, Ireland and Honorary Clinical Lecturer at Royal College of Surgeons, Ireland
Contributor content
Presentation
Association between elevated pre-percutaneous coronary intervention C-reactive protein levels and subsequent in-stent restenosis or repeat revascularization: A scoping review and meta-analysis
Presentation
Association between pre-percutaneous coronary intervention lipoprotein (a) levels and angiographically confirmed in-stent restenosis: a systematic review and study-level meta-analysis
Presentation
Meta-analysis of randomized trials: DEB versus DES in patients with de novo coronary artery disease
Presentation
C-reactive protein levels and coronary in-stent restenosis: A systematic review and meta-analysis
Presentation
Glu298Asp variant of endothelial nitric oxide synthase gene and acute or early presentation of coronary artery disease: An updated systematic review and meta-analysis
Presentation
Assessment of stent optimization in clinical practice using optical coherence tomography: a multicentric observational study
Presentation
Interleukin 6 -174 G/C polymorphism: its relation to coronary artery disease and circulating IL-6 levels- a systematic review and meta-analysis
Presentation
Morphometric and qualitative differences in neointimal tissue six months after implantation of bioresorbable scaffolds versus conventional everolimus eluting stents in ISAR-Absorb MI trial
Presentation
Optical coherence tomography tissue coverage and characterization at six months after implantation of bioresorbable scaffolds versus conventional everolimus eluting stents in the ISAR-Absorb MI trial
Presentation
